Image-guided radiotherapy for prostate cancer;Bildgesteuerte strahlentherapie des prostatakarzinoms

Aktuelle Urologie

Volumn 38, Issue 5, 2007, Pages 386-391

  Lohr, Frank ^a   Boda Heggemann, J ^a   Wenz, F ^a   Wiegel, T ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

IGRT; Image guided radiotherapy; IMRT; Intensity modulated radiotherapy; Patient positioning; Prostate cancer; Tumour localisation

Indexed keywords

RADIOACTIVE IODINE;

BODY POSTURE; COMPARATIVE STUDY; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; HUMAN; IMAGE QUALITY; INTENSITY MODULATED RADIATION THERAPY; MALE; POSITRON EMISSION TOMOGRAPHY; PROSTATE TUMOR; RADIATION DOSE; RADIATION EXPOSURE; RADIOGRAPHY; REVIEW; SCINTISCANNING; SEMINAL VESICLE;

HUMANS; IODINE RADIOISOTOPES; MALE; POSITRON-EMISSION TOMOGRAPHY; POSTURE; PROSTATIC NEOPLASMS; RADIOGRAPHIC IMAGE ENHANCEMENT; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; SEMINAL VESICLES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 35048845233     PISSN: 00017868     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-980118     Document Type: Review

References (34)

1. Bottke D, Wiegel T. Prevention of local recurrence using adjuvant radiotherapy after radical prostatectomy. Indications, results, and side effects. Urologe A 2006; 45: 1251-1254
2. Bottke D, Wiegel T. Percutaneous radiotherapy for low-risk prostate cancer: options for 2007. World J Urol 2007; 25: 53-57
3. Goldner G, Wachter S, Wachter-Gerstner N et al. Long-term results in three-dimensional conformal radiotherapy of localized prostate cancer at moderate dose (66Gy). Strahlenther Onkol 2006; 182: 537-542
4. Peeters ST, Heemsbergen WD, Koper PC et al. Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol 2006; 24: 1990-1996
5. Kupelian PA, Potters L, Khuntia D et al. Radical prostatectomy, external beam radiotherapy < 72 Gy, external beam radiotherapy > or = 72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer, Int J Radiat Oncol Biol Phys 2004; 58: 25-33
6. Pollack A, Zagars GK Starkschall G et al. Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 2002; 53: 1097-1105
7. Dobler B, Lorenz F, Wertz H et al. Intensity-modulated radiation therapy (IMRT) with different combinations of treatment-planning systems and linacs: issues and how to detect them. Strahlenther Onkol 2006; 182: 481-488
8. Zelefsky MJ, Chan H, Hunt M et al. Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer. J Urol 2006; 176: 1415-1419
9. Ganswindt U, Paulsen F, Corvin S et al. Optimized coverage of high-risk adjuvant lymph node areas in prostate cancer using a sentinel node-based, intensity-modulated radiation therapy technique. Int J Radiat Oncol Biol Phys 2007; 67: 347-355
10. Kupelian PA, Ready CA, Klein EA et al. Short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: preliminary results on late toxicity and quality of life. Int J Radiat Oncol Biol Phys 2001; 51: 988-993
11. Crook JM, Raymond Y, Saihani D et al. Prostate motion during standard radiotherapy as assessed by fiducial markers. Radiother Oncol 1995; 37: 35-42
12. Ghilezan MJ, Jaffray DA, Siewerdsen JH et al. Prostate gland motion assessed with cine-magnetic resonance imaging (cine-MRI). Int J Radiat Oncol Biol Phys 2005; 62: 406-417
13. deCrevoisier R, Tucker SL, Dong L et al. Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 2005; 62: 965-973
14. Boyer AL, Antonuk L, Fenster A et al. A review of electronic portal imaging devices (EPIDs). Med Phys 1992; 19: 1-16
15. Rudat V, Schraube P, Oetzel D et al. Combined error of patient positioning variability and prostate motion uncertainty in 3D conformal radiotherapy of localized prostate cancer. Int J Radiat Oncol Biol Phys 1996; 35: 1027-1034
16. Rudat V, Flentje M, Oetzel D et al. Influence of the positioning error on 3D conformal dose distributions during fractionated radiotherapy. Radiother Oncol 1994; 33: 56-63
17. Balter JM, Lam KL, Sandler HM et al. Automated localization of the prostate at the time of treatment using implanted radiopaque markers: technical feasibility. Int J Radiat Oncol Biol Phys 1995; 33: 1281-1286
18. Schiffner DC, Gottschalk AR, Lometti M et al. Daily electronic portal imaging of implanted gold seed fiducials in patients undergoing radiotherapy after radical prostatectomy. Int J Radiat Oncol Biol Phys 2007; 67: 610-619
19. Kupelian P, Willoughby T, Mahadevan A et al. Multi-institutional clinical experience with the calypso system in localization and continuous, real-time monitoring of the prostate gland during external radiotherapy. Int J Radiat Oncol Biol Phys 2007; 67: 1088-1098
20. Latranzi J, McNeeley S, Donnelly S et al. Ultrasound-based stereotactic guidance in prostate cancer-quantification of organ motion and set-up errors in external beam radiation therapy. Comput Aided Surg 2000; 5: 289-295
21. Lattanzi J, McNeeley S, Pinover W et al. A comparison of daily CT localization to a daily ultrasound-based system in prostate cancer. Int J Radiat Oncol Biol Phys 1999; 43: 719-725
22. Fuss M, Cavanaugh SX, Fuss C et al. Daily stereotactic ultrasound prostate targeting: Inter-user variability. Technol Cancer Res Treat 2003; 2: 161-170
23. Langen KM, Pouliot J, Anezinos C et al. Evaluation of ultrasound-based prostate localization for image-guided radiotherapy. Int J Radiat Oncol Biol Phys 2003; 57: 635-644
24. Artignan X, Rastkhah M, Balosso J et al. Quantification of prostate movements during radiotherapy. Cancer Radiother 2006; 10: 381-387
25. McNair HA, Mangar SA, Coffey J et al. A comparison of CT- and ultrasound-based imaging to localize the prostate for external beam radiotherapy, Int J Radiat Oncol Biol Phys 2006; 65: 678-687
26. Dobler B, Mai S, Ross C et al. Evaluation of possible prostate displacement induced by pressure applied during transabdominal ultrasound image acquisition. Strahlenther Onkol 2006; 182: 240-246
27. Srasi M, Munoz F, Fiorino C et al. Emptying the rectum before treatment delivery limits the variations of rectal dose-volume parameters during 3DCRT of prostate cancer. Radiother Oncol 2006; 80: 363-370
28. Hoogeman MS, Herk M van, de Bois J et al. Strategies to reduce the systematic error due to tumor and rectum motion in radiotherapy of prostate cancer. Radiother Oncol 2005; 74: 177-185
29. Wertz H, Lohr F, Dobler B et al. Dosimetric impact of image-guided translational isocenter correction for 3-d conformal radiotherapy of the prostate. Strahlenther Onkol 2007; 183: 203-210
30. Herfarth KK, Pirzkall A, Lohr F et al. First experiences with a noninvasive patient set-up system for radiotherapy of the prostate. Strahlenther Onkol 2000; 176: 217-222
31. Baum C, Alber M, Birkner M et al. Robust treatment planning for intensity modulated radiotherapy of prostate cancer based on coverage probabilities. Radiother Oncol 2006; 78: 27-35
32. Langen KM, Zhang Y, Andrews RD et al. Initial experience with megavoltage (MV) CT guidance for daily prostate alignments, Int J Radiat Oncol Biol Phys 2005; 62: 1517-1524
33. Walter C, Boda-Heggemann J, Wertz H et al. In vivo dose measurements of extra dose from cone-beam computed tomography, Int J Radiat Oncol Biol Phys 2006; 66: 632
34. Smitsmans MH, de Bois J, Sonke JJ et al. Automatic prostate localization on cone-beam CT scans for high precision image-guided radiotherapy, Int J Radiat Oncol Biol Phys 2005; 63: 975-984